Government and Regulations

FDA announces new potential side effects for varenicline


 

References

The Food and Drug Administration is warning physicians and patients that taking varenicline for smoking cessation can change a patient’s reaction to alcohol and can cause seizures* in patients without prior history.

Some patients who have drunk alcohol while taking varenicline, marketed as Chantix, have reported decreased tolerance to alcohol, including symptoms such as increased drunkenness, unusual or aggressive behavior, or memory loss. Patients have also reported incidence of seizure within a month of starting varenicline, despite having no previous history of seizure.

“Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately,” the FDA recommended.

Find the full announcement on the FDA website.

*Correction, 3/11/2015: An earlier version of this article misstated one of the side effects of varenicline.

Recommended Reading

Flu vaccine induces antibodies that help fight H7N9
MDedge Internal Medicine
Ventilator driving pressure may predict mortality in ARDS
MDedge Internal Medicine
Lung cancer screening criteria may need changes
MDedge Internal Medicine
Health care association transmission major factor in MERS-CoV outbreak
MDedge Internal Medicine
Respiratory harm reversal seen in asthmatic smokers on e-cigarettes
MDedge Internal Medicine
Reslizumab aces pivotal trials in asthma with eosinophilia
MDedge Internal Medicine
Environmental factors could increase U.S. anthrax cases
MDedge Internal Medicine
FDA panel recommends two new strains for 2015-2016 influenza vaccines
MDedge Internal Medicine
Studies of anesthesia’s effect on upper airway are limited
MDedge Internal Medicine
Microbiome and innate immunity in the respiratory tract – a primer
MDedge Internal Medicine